GLOW Lite 55mg

GLOW Lite 55mg — Research-grade compound, 99%+ purity. For research use only.

$149.00

SKU OML-GLOWLITE-55mg Categories ,
Purity :

99% (per batch COA)

Form :

Lyophilized powder

Size :

55mg

Storage :

-20°C (lyophilized), 4°C (reconstituted)

Batch :

OML-GLOWLITE-55mg

Our Third-Party Testing Commitment

Overmatch Labs does not sell any compound or peptide that has not passed independent third-party laboratory testing at 99%+ purity. Every batch is tested by an accredited third-party laboratory — not our own facility — to ensure unbiased verification of identity, purity, and endotoxin levels. We believe transparent, verifiable science is the foundation of trust.

Description

GLOW Lite 55mg is a research-use-only multi-peptide blend. Each component is third-party HPLC tested to ≥ 99% purity with a batch Certificate of Analysis. Supplied strictly for laboratory research use only — not for human or veterinary consumption.

Certificate of Analysis Document

Detailed purity verification and batch analysis results

Research

Scientific research related to this compound

Use the References list below as the research summary, or leave blank.

References

Citations and reference materials

No curated citations available — source 2–3 peer-reviewed references before publishing.

Mechanism of Action

How this compound works at a biological level

No RUO-safe mechanism source available — leave blank or source from peer-reviewed literature.

Technical Details

Specifications, properties, and technical data

  • Compound type: Peptide
  • Physical form: Lyophilized powder
  • Purity: ≥ 99% (HPLC; see batch Certificate of Analysis)
  • Size: 55mg
  • Storage: -20°C (lyophilized), 4°C (reconstituted)

Related Products

Age & Research Verification

I acknowledge that all products are sold strictly for Research Use Only (RUO) and are not intended for human consumption, veterinary use, or as food additives.
Are you 21 or older?

Verification Required

Please confirm your age and acceptance of the Research Use Only policy to continue